Further evidence for role of Ki-67 as a prognostic marker in early-stage non-small cell lung cancer

Access to the full content of this site is available only to registered healthcare professionals. Register to read more

Takeaway

  • Elevated Ki-67 expression was associated with a poorer outcome in non-small cell lung cancer (NSCLC) patients, particularly in early-stage Asian adenocarcinoma (ADC) patients, though studies with larger numbers of patients are needed to validate these findings.

Study design

  • Th...